SCHEMBL18157775

SCHEMBL18157775

C(=C/c1[nH]c2ccccc2c1/C=C/c1nccs1)\c1nccs1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIOK2 Q9BVS4 1/20 0.53
MAPT P10636 6/20 0.47
KMT2A Q03164 5/20 0.47
MEN1 O00255 4/20 0.47
RAB9A P51151 4/20 0.47
CYP1A2 P05177 3/20 0.47
CYP2D6 P10635 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
NPC1 O15118 3/20 0.47
CYP3A4 P08684 2/20 0.47
TP53 P04637 1/20 0.47
GAA P10253 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
MAPK10 P53779 1/20 0.47
PLK4 O00444 1/20 0.40
FLT3 P36888 1/20 0.40
NR1H2 P55055 1/20 0.39
ALDH1A1 P00352 5/20 0.37
HSD17B10 Q99714 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18157780 0.78 PADI4 (0.41) MAPTKMT2AMEN1RAB9ACYP1A2
SCHEMBL18157756 0.77 KMT2A (0.52) MAPTKMT2AMEN1RAB9ACYP1A2
SCHEMBL18160331 0.74 MAPT (0.47) MAPTKMT2AMEN1RAB9ACYP1A2
SCHEMBL18157751 0.73 NPC1 (0.39) MAPTKMT2AMEN1RAB9ACYP1A2
SCHEMBL18160332 0.73 KDM4E (0.39) MAPTKMT2AMEN1RAB9ACYP1A2
SCHEMBL28555372 0.73 NPC1 (0.50) MAPTKMT2AMEN1RAB9ACYP1A2
SCHEMBL18157755 0.73 NPC1 (0.50) MAPTKMT2AMEN1RAB9ACYP1A2
SCHEMBL18157766 0.72 ALK (0.39) MAPTKMT2AMEN1RAB9ACYP1A2
SCHEMBL18160299 0.72 NPC1 (0.35) MAPTKMT2AMEN1RAB9ACYP1A2
SCHEMBL18157762 0.72 ALK (0.50) MAPTKMT2AMEN1RAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10239834-B2 Antibiotic sensitivity-restoring and photosensitive agents NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION (US) 2019-03-26 US disclosed
US-20180155286-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION 2018-06-07 US disclosed
US-20180155286-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION 2018-06-07 US disclosed
US-9834514-B2 Antibiotic sensitivity-restoring and photosensitive agents NEW MEXICO TECH RESEARCH FOUNDATION (US) 2017-12-05 US disclosed
US-9834514-B2 Antibiotic sensitivity-restoring and photosensitive agents NEW MEXICO TECH RESEARCH FOUNDATION (US) 2017-12-05 US disclosed
US-20160304453-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION 2016-10-20 US disclosed
US-20160304453-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10239834-B2 Antibiotic sensitivity-restoring and photosensitive agents XPA, PPOX, ALAD RIOK2 3261/4885MAPT 2538/4885KMT2A 2258/4885
US-20180155286-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS XPA, PPOX, ALAD RIOK2 3261/4885MAPT 2538/4885KMT2A 2258/4885
US-20160304453-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS XPA, PPOX, ALAD RIOK2 3261/4885MAPT 2538/4885KMT2A 2258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.